Physician profile
Thomas T Park
NPI 1629169412
$3,967.71
in general payments reported to CMS, 2019-2025
23 companies · $95.28 in 2025
The $95.28 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $827 · 2020: $231 · 2021: $1,017 · 2022: $1,176 · 2023: $431 · 2024: $190 · 2025: $95.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $702.74 | 2020-2024 | Perseris, Sublocade |
| Abbvie INC. | $546.41 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $450.89 | 2019-2025 | Invega Sustenna |
| Avanir Pharmaceuticals, INC. | $409.08 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $390.78 | 2019-2025 | Abilify Maintena |
| Teva Pharmaceuticals USA, INC. | $327.90 | 2019-2022 | |
| Alkermes, INC. | $220.52 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $209.30 | 2021-2022 | |
| Lundbeck LLC | $168.55 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $97.55 | 2020-2022 | |
| Corium, LLC | $95.37 | 2022 | |
| Shire North American Group INC | $73.62 | 2019 | |
| Supernus Pharmaceuticals, INC. | $55.15 | 2022-2023 | Qelbree |
| Allergan, INC. | $52.82 | 2019-2020 | |
| Almatica Pharma LLC | $36.74 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $24.71 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $22.39 | 2025 | Cobenfy |
| Tris Pharma INC | $16.72 | 2022 | |
| Jazz Pharmaceuticals INC. | $15.56 | 2022 | |
| Bausch Health US, LLC | $13.97 | 2021 | |
| Axsome Therapeutics, INC. | $13.10 | 2024 | Auvelity |
| Noven Therapeutics, LLC | $12.84 | 2021 | |
| Ironshore Pharmaceuticals INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.